Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01381224 · ClinicalTrials.gov registry record
Do Lower Spine Injections Improve Outcomes for Lower Back Pain Patients
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 30
- Enrollment target
NCT01381224: Completed study, sponsored by University of Florida.
NCT01381224 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01381224 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this project is to determine the effect of lower back injections on select biomechanical outcomes, walking patterns, lower back flexibility and balance.
Primary Outcome
We hypothesize that patients will demonstrate increased gait velocity, increased step length, decreased asymmetry and increased lumbar ROM immediately after injection compared to pre-injection
Interventions
- OTHER Observation of biomechanical effects post injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-10 |
What the finished NCT01381224 record still lists
NCT01381224 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Observation of biomechanical effects post injection is the first listed.
NCT01381224 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01381224 about?
NCT01381224 is a clinical study titled "Do Lower Spine Injections Improve Outcomes for Lower Back Pain Patients". The purpose of this project is to determine the effect of lower back injections on select biomechanical outcomes, walking patterns, lower back flexibility and balance.
What is the current status of trial NCT01381224?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2011-01. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01381224?
The interventions under investigation include: Observation of biomechanical effects post injection (OTHER).
Who is sponsoring clinical trial NCT01381224?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia